AMED has a market capitalization of $7,896,512,421 -- more than approximately 81.15% of US stocks.
AMED's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 454.12 -- higher than 92.51% of US-listed equities with positive expected earnings growth.
Price to trailing twelve month operating cash flow for AMED is currently 26.48, higher than 83.81% of US stocks with positive operating cash flow.
If you're looking for stocks that are quantitatively similar to Amedisys Inc, a group of peers worth examining would be EHC, USM, EXPD, MORN, and RS.
AMED's SEC filings can be seen here. And to visit Amedisys Inc's official web site, go to www.amedisys.com.
Amedisys provides home health and hospice care services. It operates through two segments, Home Health and Hospice. The company was founded in 1982 and is based in Baton Rouge, Louisiana.
AMED Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Amedisys Inc. To summarize, we found that Amedisys Inc ranked in the 50th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 18.33% on a DCF basis. In terms of the factors that were most noteworthy in this DCF analysis for AMED, they are:
The company's debt burden, as measured by earnings divided by interest payments, is 16.91 -- which is good for besting 78.16% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
The business' balance sheet reveals debt to be 5% of the company's capital (with equity being the remaining amount). Approximately merely 15.17% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
AMED's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 43.83% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as AMED, try EGRX, INBP, QDEL, SNY, and LCI.
Amedisys (AMED) signed a Care Coordination Agreement with BrightStar Care in order to add its agencies to the Amedisys Personal Care Network and facilitate the coordination of care between the former's hospice and home health care centers and personal care partners network.BrightStar Care’s 340 personal care locations in 38 states...
Amedisys, Inc. (AMED) Q2 2020 Earnings Conference Call July 29, 2020 11:00 AM ET Company Participants Nick Muscato - Vice President of Strategic Finance Paul Kusserow - President & Chief Executive Officer Scott Ginn - Chief Financial Officer Chris Gerard - Chief Operating Officer Conference Call Participants Brian Tanquilut -...
Amedisys (AMED) is expected to report earnings on Jul. 28. Amedisys now trading 2% below the 218.54 buy point from a fourth-stage consolidation that it cleared earlier. Understand that it's risky to buy any stock just before it reports. You can reduce your risk by waiting to see the actual numbers and the market's reaction. Looking For The Best Stocks...